Global PDX Models Market Growth (Status and Outlook) 2025-2031

According to this study, the global PDX Models market size will reach US$ 685 million by 2031.

Patient-derived xenografts (PDX) are a model of cancer in which tissues or cells from a patient"s tumor are implanted in immunodeficient or humanized mice. The PDX model is used to create an environment that allows the cancer to grow naturally, monitor and evaluate the original patient"s treatment accordingly.

Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.

LPI (LP Information)' newest research report, the “PDX Models Industry Forecast” looks at past sales and reviews total world PDX Models sales in 2024, providing a comprehensive analysis by region and market sector of projected PDX Models sales for 2025 through 2031. With PDX Models sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PDX Models industry.

This Insight Report provides a comprehensive analysis of the global PDX Models landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PDX Models portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PDX Models market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PDX Models and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PDX Models.

This report presents a comprehensive overview, market shares, and growth opportunities of PDX Models market by product type, application, key players and key regions and countries.

Segmentation by Type:
Mice Models
Rat Models

Segmentation by Application:
Preclinical Drug Development and Oncology Research
Biomarker Analysis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Crown Bioscience
Champion Oncology
The Jackson Laboratory
Oncodesign
Wuxi Apptec
Horizon Discovery Group
Pharmatest Services
MI Bioresearch
Creative Animodel
Urosphere
Xentech
Hera BioLabs
EPO Berlin-Buch

Please note: The report will take approximately 2 business days to prepare and deliver. Show more